Why Is ACADIA HEALTHCARE CO (ACHC) Stock Down Today?

ACHC stock is down 16.34% as of the close at $27.35. The drop follows the release of second-quarter 2026 earnings and guidance updates by Acadia Healthcare. While the company raised full-year adjusted EPS and revenue guidance, the market reacted negatively to the revised forecast and the broader financial picture.

What Happened

Acadia Healthcare reported Q2 2026 results and updated its full-year 2026 guidance. The company raised its adjusted EPS guidance from $1.35-$1.60 to $1.45-$1.60, and its revenue guidance from $3.370B-$3.450B to $3.400B-$3.450B. However, the stock declined sharply following the earnings call and related disclosures. The company emphasized free cash flow and EBITDA performance, as well as plans for bed expansion, but the market appeared to focus on underlying profitability challenges. An SEC 8-K filing on July 28 detailed the company’s results of operations and financial condition, including a negative net margin and unprofitable earnings per share. The Q2 earnings call transcript and slide deck, published on July 29, further outlined key risks and financial updates.

What The Data Shows

Acadia Healthcare has a market cap of $3.0B and is currently unprofitable, with a trailing twelve-month EPS of -12.24. Despite a 6.8% revenue increase in the trailing twelve months, the company’s net margin remains at -32.8%. The stock has traded between $11.43 and $35.83 over the past 52 weeks. The recent decline to $27.35 places it near the lower end of its 52-week range. The stock’s beta of 0.64 indicates it is less volatile than the broader market. There has been minimal social media chatter, with only one post in the last 24 hours and one in the past week.

What To Watch

The stock is scheduled to report no further earnings in the near term. Investors should monitor the breadth of coverage and analyst reactions as the market digests the revised guidance and ongoing financial performance.